Maxele Advisors’s Lam Research LRCX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-4,960
Closed -$483K 100
2025
Q2
$483K Buy
4,960
+400
+9% +$31.7K 0.42% 54
2025
Q1
$332K Sell
4,560
-110
-2% -$8.66K 0.32% 72
2024
Q4
$337K Buy
+4,670
New +$354K 0.32% 69
2022
Q3
Sell
-5,130
Closed -$219K 82
2022
Q2
$219K Sell
5,130
-920
-15% -$43.8K 0.34% 77
2022
Q1
$325K Sell
6,050
-300
-5% -$17.5K 0.4% 63
2021
Q4
$457K Buy
+6,350
New +$398K 0.53% 51

Other funds holding LRCX

Maxele Advisors's LRCX Position: Q3 2025 in Review

Maxele Advisors sold out of Lam Research (LRCX) in Q3 2025, closing a stake of 4,960 shares — an estimated $483K sold.

Maxele Advisors first reported a position in LRCX in Q4 2021 and held it in 6 quarters. The position peaked at $483K in Q2 2025. 2,110 funds tracked by Wall St. Rank hold LRCX as of Q3 2025.

  • Maxele Advisors reported no remaining Lam Research position as of Q3 2025 after selling out during the quarter.
  • Maxele Advisors sold 4,960 Lam Research shares in Q3 2025, an estimated $483K.
  • Maxele Advisors first reported a position in Lam Research in Q4 2021 and held it in 6 quarters.
  • Maxele Advisors's Lam Research position peaked at $483K in Q2 2025.
  • 2,110 funds tracked by Wall St. Rank held Lam Research as of Q3 2025.

Based on Maxele Advisors's 13F filing for Q3 2025, filed 14 Nov 2025.